Bimodal Effect on Pancreatic β-Cells of Secretory Products From Normal or Insulin-Resistant Human Skeletal Muscle
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Type 2 diabetes is characterized by insulin resistance with a relative deficiency in insulin secretion. This study explored the potential communication between insulin-resistant human skeletal muscle and primary (human and rat) β-cells. RESEARCH DESIGN AND METHODS: Human skeletal muscle cells were cultured for up to 24 h with tumor necrosis factor (TNF)-α to induce insulin resistance, and mRNA expression for cytokines was analyzed and compared with controls (without TNF-α). Conditioned media were collected and candidate cytokines were measured by antibody array. Human and rat primary β-cells were used to explore the impact of exposure to conditioned media for 24 h on apoptosis, proliferation, short-term insulin secretion, and key signaling protein phosphorylation and expression. RESULTS: Human myotubes express and release a different panel of myokines depending on their insulin sensitivity, with each panel exerting differential effects on β-cells. Conditioned medium from control myotubes increased proliferation and glucose-stimulated insulin secretion (GSIS) from primary β-cells, whereas conditioned medium from TNF-α–treated insulin-resistant myotubes (TMs) exerted detrimental effects that were either independent (increased apoptosis and decreased proliferation) or dependent on the presence of TNF-α in TM (blunted GSIS). Knockdown of β-cell mitogen-activated protein 4 kinase 4 prevented these effects. Glucagon-like peptide 1 protected β-cells against decreased proliferation and apoptosis evoked by TMs, while interleukin-1 receptor antagonist only prevented the latter. CONCLUSIONS: Taken together, these data suggest a possible new route of communication between skeletal muscle and β-cells that is modulated by insulin resistance and could contribute to normal β-cell functional mass in healthy subjects, as well as the decrease seen in type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“TNFα secretion from T2D subjects was higher than healthy controls,207,208 and one in vitro study has shown that this myokine impairs beta-cell function.208”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [208]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredIn the citing paper
“TNFα secretion from T2D subjects was higher than healthy controls,207,208 and one in vitro study has shown that this myokine impairs beta-cell function.208”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [208]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Maedler, K., Schumann, D. M., Sauter, N., Ellingsgaard, H., Bosco, D., Baertschiger, R., Iwakura, Y., Oberholzer, J., Wollheim, C. B., Gauthier, B. R., et al. (2006) · Diabetes · doi:10.2337/db05-1430 · Cited by 156
Self-citationRetractedMechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448 · cited 1×
“To understand the mechanism involved in type 2 diabetes development, peripheral insulin resistance and b-cell function have to be studied in parallel (36,37).”
BackgroundC-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433 · cited 1×
“Low-grade systemic inflammation is also a feature of obesity and diabetes (38), raising the hypothesis that elevated cytokine levels may contribute to insulin resistance and decreased b-cell functional mass (39).”
Backgroundβ-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
Disruption of IRS-2 causes type 2 diabetes in mice
Withers, D. J., Gutierrez, J. S., Towery, H., Burks, D. J., Ren, J.-M., Previs, S., Zhang, Y., Bernal, D., Pons, S., Shulman, G. I., et al. (1998) · Nature · doi:10.1038/36116 · Cited by 1,775 · cited 1×
“IRS-1 and -2 have been shown to be central in both insulin production and secretion (27,28).”
BackgroundMasters, S. L., Dunne, A., Subramanian, S. L., Hull, R. L., Tannahill, G. M., Sharp, F. A., Becker, C., Franchi, L., Yoshihara, E., Chen, Z., et al. (2010) · Nature Immunology · doi:10.1038/ni.1935 · Cited by 1,330 · cited 1×
“2 and 3), which has been shown to be involved in type 2 diabetes (30,31).”
BackgroundGenetics, pathogenesis and clinical interventions in type 1 diabetes
Bluestone, J. A., Herold, K., & Eisenbarth, G. (2010) · Nature · doi:10.1038/nature08933 · Cited by 1,265 · cited 1×
“Type 1 (insulindependent) diabetes thus results from autoimmune destruction of pancreatic b-cells (1), and it is now recognized that there is decreased b-cell mass and function in type 2 diabetes (2) but the precise underlying mechanism remains to be determined.”
BackgroundIncreased Number of Islet-Associated Macrophages in Type 2 Diabetes
Ehses, J. A., Perren, A., Eppler, E., Ribaux, P., Pospisilik, J. A., Maor-Cahn, R., Gueripel, X., Ellingsgaard, H., Schneider, M. K. J., Biollaz, G., et al. (2007) · Diabetes · doi:10.2337/db06-1650 · Cited by 783
Self-citationPlomgaard, P., Bouzakri, K., Krogh-Madsen, R., Mittendorfer, B., Zierath, J. R., & Pedersen, B. K. (2005) · Diabetes · doi:10.2337/diabetes.54.10.2939 · Cited by 627 · cited 2×
“We showed previously that TNF-a can induce insulin resistance in human skeletal muscle by altering the insulin signaling pathway (16), providing a unique system for molecular dissection in vitro (17).”
BackgroundSelf-citationGlucagon-like Peptide-1 Receptor Signaling Modulates β Cell Apoptosis
Li, Y., Hansotia, T., Yusta, B., Ris, F., Halban, P. A., & Drucker, D. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209423200 · Cited by 589
Self-citationOrally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation
Aouadi, M., Tesz, G. J., Nicoloro, S. M., Wang, M., Chouinard, M., Soto, E., Ostroff, G. R., & Czech, M. P. (2009) · Nature · doi:10.1038/nature07774 · Cited by 573 · cited 3×
“MAP4K4 has been shown to mediate TNF-a action in adipose tissue, skeletal muscle, and b-cells (11,17,29).”
BackgroundResultThe Role of Exercise-Induced Myokines in Muscle Homeostasis and the Defense against Chronic Diseases
Brandt, C., & Pedersen, B. K. (2010) · Journal of Biomedicine and Biotechnology · doi:10.1155/2010/520258 · Cited by 430 · cited 1×
“Nowadays, skeletal muscle is accepted as an endocrine organ (40).”
BackgroundSelf-citationFGF21 is an Akt‐regulated myokine
Izumiya, Y., Bina, H. A., Ouchi, N., Akasaki, Y., Kharitonenkov, A., & Walsh, K. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.10.021 · Cited by 415 · cited 1×
“different cytokines depending on their state of insulin sensitivity, adding to the list of previously known myokines (41,42).”
BackgroundAn immune origin of type 2 diabetes?
Kolb, H., & Mandrup-Poulsen, T. (2005) · Diabetologia · doi:10.1007/s00125-005-1764-9 · Cited by 394 · cited 3×
“Myokines like IL-1b, IL-6, TNF-a, CCL5, MCP-1, IL-8, and CXCL10 are good candidates for these latter, detrimental actions as they have been shown to impact negatively on b-cell function and survival (5,9–13).”
BackgroundInsulin action and insulin resistance in human skeletal muscle
Zierath, J. R., Krook, A., & Wallberg-Henriksson, H. (2000) · Diabetologia · doi:10.1007/s001250051457 · Cited by 367 · cited 1×
“Skeletal muscle plays a major role in whole-body substrate homeostasis in the postprandial state, and impaired action on this tissue contributes to the pathological condition of insulin resistance (14).”
BackgroundIL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat
Ehses, J. A., Lacraz, G., Giroix, M.-H., Schmidlin, F., Coulaud, J., Kassis, N., Irminger, J.-C., Kergoat, M., Portha, B., Homo-Delarche, F., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810087106 · Cited by 347 · cited 1×
“2 and 3), which has been shown to be involved in type 2 diabetes (30,31).”
BackgroundSelf-citationOuchi, N., Oshima, Y., Ohashi, K., Higuchi, A., Ikegami, C., Izumiya, Y., & Walsh, K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803440200 · Cited by 338 · cited 1×
“different cytokines depending on their state of insulin sensitivity, adding to the list of previously known myokines (41,42).”
BackgroundHandschin, C., Choi, C. S., Chin, S., Kim, S., Kawamori, D., Kurpad, A. J., Neubauer, N., Hu, J., Mootha, V. K., Kim, Y.-B., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31785 · Cited by 335
Islet Inflammation in Type 2 Diabetes
Donath, M. Y., Schumann, D. M., Faulenbach, M., Ellingsgaard, H., Perren, A., & Ehses, J. A. (2008) · Diabetes Care · doi:10.2337/dc08-s243 · Cited by 334 · cited 1×
“Low-grade systemic inflammation is also a feature of obesity and diabetes (38), raising the hypothesis that elevated cytokine levels may contribute to insulin resistance and decreased b-cell functional mass (39).”
BackgroundSelf-citationThe metabolic role of IL-6 produced during exercise: is IL-6 an exercise factor?
Pedersen, B. K., Steensberg, A., Fischer, C., Keller, C., Keller, P., Plomgaard, P., Wolsk-Petersen, E., & Febbraio, M. (2004) · Proceedings of the Nutrition Society · doi:10.1079/pns2004338 · Cited by 272 · cited 2×
“Interleukin (IL)-6 is the prototype myokine and was identified as the first long-searched-for muscle contraction–induced factor (4).”
BackgroundSelf-citationInterleukin-6 regulates pancreatic α-cell mass expansion
Ellingsgaard, H., Ehses, J. A., Hammar, E. B., Van Lommel, L., Quintens, R., Martens, G., Kerr-Conte, J., Pattou, F., Berney, T., Pipeleers, D., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801059105 · Cited by 269
Self-citationInsulin receptor substrate 2 plays a crucial role in β cells and the hypothalamus
Kubota, N., Terauchi, Y., Tobe, K., Yano, W., Suzuki, R., Ueki, K., Takamoto, I., Satoh, H., Maki, T., Kubota, T., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21484 · Cited by 239 · cited 1×
“Moreover, IRS-2 is known to be indispensable for b-cell function (43) while ERK activation has been shown to be involved in GSIS (44).”
BackgroundBlockade of interleukin 1 in type 1 diabetes mellitus
Mandrup-Poulsen, T., Pickersgill, L., & Donath, M. Y. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.271 · Cited by 237 · cited 5×
“We also show that human myotubes treated with TNF-a for 24 h show an increase of several cytokines including IL-1b (Figs.”
BackgroundInfluentialSelf-citationProliferation of sorted human and rat beta cells
Parnaud, G., Bosco, D., Berney, T., Pattou, F., Kerr-Conte, J., Donath, M. Y., Bruun, C., Mandrup-Poulsen, T., Billestrup, N., & Halban, P. A. (2007) · Diabetologia · doi:10.1007/s00125-007-0855-1 · Cited by 232 · cited 5×
“Studies have shown that GLP-1 treatment can protect b-cells from the negative actions of cytokines (34,35) and also enhances primary rat b-cell proliferation (21).”
BackgroundMethodInfluentialSelf-citationWijesekara, N., Krishnamurthy, M., Bhattacharjee, A., Suhail, A., Sweeney, G., & Wheeler, M. B. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.085084 · Cited by 229 · cited 2×
“Adiponectin, first identified as a secretory product of adipocytes, has also been shown to be secreted by skeletal muscles (6) and can impact positively on pancreatic b-cell function and survival (7).”
BackgroundBouzakri, K., Zachrisson, A., Al-Khalili, L., Zhang, B. B., Koistinen, H. A., Krook, A., & Zierath, J. R. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.04.008 · Cited by 217 · cited 1×
“This supports findings in other tissues that IRS-1 and -2 have separate and nonredundant function (45).”
ResultSelf-citationCXCL10 Impairs β Cell Function and Viability in Diabetes through TLR4 Signaling
Schulthess, F. T., Paroni, F., Sauter, N. S., Shu, L., Ribaux, P., Haataja, L., Strieter, R. M., Oberholzer, J., King, C. C., & Maedler, K. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.01.003 · Cited by 208 · cited 3×
“Myokines like IL-1b, IL-6, TNF-a, CCL5, MCP-1, IL-8, and CXCL10 are good candidates for these latter, detrimental actions as they have been shown to impact negatively on b-cell function and survival (5,9–13).”
BackgroundArgilés, J. M., López-Soriano, J., Almendro, V., Busquets, S., & López-Soriano, F. J. (2005) · Medicinal Research Reviews · doi:10.1002/med.20010 · Cited by 194 · cited 1×
“TNF-a is, however, believed to be a major cytokine involved in the “conversation” between adipose tissue and muscle with increased levels in obesity and type 2 diabetes possibly contributing to insulin resistance in skeletal muscle (19).”
BackgroundThe Stunned β Cell: A Brief History
Ferrannini, E. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.04.009 · Cited by 175 · cited 1×
“It has been further postulated that the diabetogenic environment, including insulin resistance and lowgrade systemic and localized islet inflammation, contribute toward b-cell “stunning” (47).”
BackgroundDickson, L. M., & Rhodes, C. J. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00031.2004 · Cited by 159
Bouzakri, K., & Zierath, J. R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608602200 · Cited by 154 · cited 7×
“Nonmuscle-derived TNF-a contributes to insulin resistance in human skeletal muscle (16,17) and can also inhibit insulin secretion (11).”
BackgroundMethodResultInfluentialSelf-citationAssmann, A., Ueki, K., Winnay, J. N., Kadowaki, T., & Kulkarni, R. N. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01489-08 · Cited by 148
Lingohr, M. K., Dickson, L. M., McCuaig, J. F., Hugl, S. R., Twardzik, D. R., & Rhodes, C. J. (2002) · Diabetes · doi:10.2337/diabetes.51.4.966 · Cited by 147
Cornu, M., Yang, J.-Y., Jaccard, E., Poussin, C., Widmann, C., & Thorens, B. (2009) · Diabetes · doi:10.2337/db09-0063 · Cited by 146
Tesz, G. J., Guilherme, A., Guntur, K. V. P., Hubbard, A. C., Tang, X., Chawla, A., & Czech, M. P. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700665200 · Cited by 95
Kulkarni, R. N., Roper, M. G., Dahlgren, G., Shih, D. Q., Kauri, L. M., Peters, J. L., Stoffel, M., & Kennedy, R. T. (2004) · Diabetes · doi:10.2337/diabetes.53.6.1517 · Cited by 92
Rouiller, D. G., Cirulli, V., & Halban, P. A. (1991) · Developmental Biology · doi:10.1016/0012-1606(91)90332-w · Cited by 91
Self-citationThe protein kinases ERK1/2 and their roles in pancreatic beta cells
Lawrence, M., Shao, C., Duan, L., McGlynn, K., & Cobb, M. H. (2008) · Acta Physiologica · doi:10.1111/j.1748-1716.2007.01785.x · Cited by 89 · cited 1×
“Moreover, IRS-2 is known to be indispensable for b-cell function (43) while ERK activation has been shown to be involved in GSIS (44).”
BackgroundLiu, Y., Chewchuk, S., Lavigne, C., Brûlé, S., Pilon, G., Houde, V., Xu, A., Marette, A., & Sweeney, G. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00186.2009 · Cited by 86 · cited 1×
“Adiponectin, first identified as a secretory product of adipocytes, has also been shown to be secreted by skeletal muscles (6) and can impact positively on pancreatic b-cell function and survival (7).”
BackgroundMetabolic Syndrome: A Solution in Search of a Problem
Ferrannini, E. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0944 · Cited by 78
Growth factor control of pancreatic islet regeneration and function
Assmann, A., Hinault, C., & Kulkarni, R. N. (2009) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2008.00468.x · Cited by 68 · cited 1×
“In b-cells, activation of the insulin-signaling pathway is necessary to mediate glucose action (23) with IRS-2/Akt/ AS160 involved in GSIS (22).”
BackgroundBouzakri, K., Ribaux, P., & Halban, P. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.048058 · Cited by 65
Self-citationBouzakri, K., Ribaux, P., Tomas, A., Parnaud, G., Rickenbach, K., & Halban, P. A. (2008) · Diabetes · doi:10.2337/db07-1469 · Cited by 59 · cited 5×
“In b-cells, activation of the insulin-signaling pathway is necessary to mediate glucose action (23) with IRS-2/Akt/ AS160 involved in GSIS (22).”
BackgroundMethodInfluentialSelf-citationReappraising the stereotypes of diabetes in the modern diabetogenic environment
Wentworth, J. M., Fourlanos, S., & Harrison, L. C. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.149 · Cited by 57 · cited 1×
“Insulin resistance is obviously a key player in type 2 diabetes, but it also plays a larger role in the disease process of type 1 diabetes than is commonly recognized (3).”
BackgroundTissue specificity on insulin action and resistance: past to recent mechanisms
Benito, M. (2010) · Acta Physiologica · doi:10.1111/j.1748-1716.2010.02201.x · Cited by 56 · cited 2×
“The physiological source of increased circulating levels of TNF-a in type 2 diabetes remains unclear, but it does not appear to be the muscle itself (18).”
BackgroundRibaux, P., Ehses, J. A., Lin-Marq, N., Carrozzino, F., Böni‐Schnetzler, M., Hammar, E. B., Irminger, J.-C., Donath, M. Y., & Halban, P. A. (2007) · Endocrinology · doi:10.1210/en.2007-0325 · Cited by 54 · cited 1×
“This seemingly paradoxical observation can be explained by the fact that b-cells plated as here on extracellular matrix secrete low levels of IL-1b that impact positively on b-cell survival (32), which is in keeping with the established bimodal effects of this cytokine on b-cells (33).”
ResultSelf-citationHinault, C., OBBERGHEN, E. V., & Mothe‐Satney, I. (2006) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2006.02.008 · Cited by 41 · cited 1×
“During the last years, multiple studies have been performed to understand the mechanism of insulin resistance (15).”
Background
Cited by
Muscles, exercise and obesity: skeletal muscle as a secretory organ
Pedersen, B. K., & Febbraio, M. A. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.49 · Cited by 2,909
Self-citationExercise Metabolism and the Molecular Regulation of Skeletal Muscle Adaptation
Egan, B., & Zierath, J. R. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2012.12.012 · Cited by 2,084
“In vitro studies reveal that glucose-stimulated insulin release from b cells is impaired when exposed to secretions from insulin-resistant muscle cells, but not by secretions from insulin-sensitive cells (Bouzakri et al., 2011).”
BackgroundMuscle–Organ Crosstalk: The Emerging Roles of Myokines
Severinsen, M. C. K., & Pedersen, B. K. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa016 · Cited by 1,226
Self-citationInterleukin‐6 myokine signaling in skeletal muscle: a double‐edged sword?
Muñoz‐Cánoves, P., Scheele, C., Pedersen, B. K., & Serrano, A. L. (2013) · The FEBS Journal · doi:10.1111/febs.12338 · Cited by 774
Self-citationAnti-inflammatory effects of exercise: role in diabetes and cardiovascular disease
Pedersen, B. K. (2017) · European Journal of Clinical Investigation · doi:10.1111/eci.12781 · Cited by 617
Self-citation
Metadata
- Authors
- Bouzakri, K., Plomgaard, P., Berney, T., Donath, M. Y., Pedersen, B. K., & Halban, P. A.
- Affiliations
- University of Geneva (CH)
- University of Copenhagen (DK)
- University Hospital of Geneva (CH)
- University Hospital of Basel (CH)
- Department of Infectious Diseases and the Copenhagen Muscle Research Centre, The Centre of Inflammation and Metabolism, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark
- Corresponding author
- Bouzakri, Karim
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2011-03-22
- Volume
- 60
- Issue
- 4
- Pages
- 1111-1121
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC3064085
- OpenAlex
- W2170623101
- Cited by
- 122
- References
- 47
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 4 · 2023: 7 · 2022: 9 · 2021: 9 · 2020: 9 · 2019: 8 · 2018: 8 · 2017: 12 · 2016: 10 · 2015: 9 · 2014: 12 · 2013: 10 · 2012: 5
- FWCI
- 9.48
- Type
- journal article
- Language
- en
- Update notices
- correction (2015-01-01)
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion)
- HAL (submittedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- Strategiske Forskningsråd (09-067009 and 09-075724, 09–067009, 09 – 075724)
- Sundhed og Sygdom, Det Frie Forskningsråd
- National Research Foundation
- Danmarks Grundforskningsfond (# 02-512-55, 09-067009, 09-075724)
- Ministério da Ciência, Tecnologia e Inovação
- Region Hovedstaden
- Université de Genève
- Diabetesforeningen
- Medical Research Council
- Center for Strategic Research
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- pancreatic beta cells, skeletal muscle, insulin resistance, type 2 diabetes, myokines, TNF-α, glucose-stimulated insulin secretion, beta-cell apoptosis, beta-cell proliferation, MAPK4, glucagon-like peptide-1, interleukin-1 receptor antagonist, cytokines
- MeSH terms
- Insulin Secretion, Animals, Cells, Cultured, Humans, Insulin, Insulin Resistance, Male, Tumor Necrosis Factor-alpha, Cytokines, Culture Media, Conditioned, Rats, Wistar, Apoptosis, Protein Serine-Threonine Kinases, Muscle Fibers, Skeletal, In Situ Nick-End Labeling, RNA Interference, Cell Proliferation, Insulin-Secreting Cells, Rats, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.